ECITA Abstract Deadline: Dec 01, 2023
Regular Abstract Deadline: Dec 05, 2023*
* Deadline for publication of abstract in the NeuroImmune Pharmacology and Therapeutics.
Abstracts submitted for the 28th Scientific Conference in Charleston, SC, March 10 - 13, 2024, will be posted online at the SNIP Website. Authors not wanting their abstract to be posted online and/or publish in the NeuroImmune Pharmacology and Therapeutics can obtain an exemption from this policy by writing to Santhi Gorantla, PhD at firstname.lastname@example.org before Dec 05, 2023. In submitting this abstract, all authors indicate their agreement with this policy unless a request for exemption is received prior to Dec 05, 2023. Sending an abstract recognizes the right of the Society to publish the abstract on its website and journal unless an exemption is claimed in writing in advance.
Please submit ECITA abstracts here. A recommendation letter from the trainee’s advisor or department chair, confirming their status as a graduate student or postdoctoral fellow, must accompany all requests for a travel grant. All requests for a travel grant must be accompanied by a current NIH biosketch or CV of the student or postdoctoral fellow. Please address the letter to the attention of the "ECITA Selection Committee" and forward the letter and Bio to the ECITA Chair, Jerel Adam Fields, Ph.D. (email@example.com). Electronic signatures and scanned copies will be accepted. Trainees who have not confirmed their status by providing a letter from their advisor or department chair will not be eligible to receive a travel grant.
You may type your abstract directly into the field or cut and paste from a text document. No more than 1,600 characters (including spaces) are allowed. Use Font Arial size 11. Please check with the Preview button below to assure that your entire abstract is displayed and adjust it as needed to fit. Do not use any symbols or special characters as they will not appear correctly in the final text.
Important: Please do not use any symbols or special characters as they will not appear correctly in the final text
A) individuals from underrepresented racial and ethnic groups shown to be underrepresented nationally (see data at http://www.nsf.gov/statistics/showpub.cfm?TopID=2&SubID=27 and the report Women, Minorities, and Persons with Disabilities in Science and Engineering) defined as Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Native Hawaiians and other Pacific Islanders and
B) individuals with disabilities, defined as those with a physical or mental impairment that substantially limits one or more major life activities.
Click the Add Additional Institution button to enter additional institutions associated with co-authors, if different than that entered for Institution #1.
Click the Add Additional Author button to enter additional co-authors.
(1) - Click on the Preview button to preview your abstract before submission to the system.
(2) - Once everything is correct, please click the Submit Abstract button to accept all terms and submit your abstract.
You will be notified by an email that the abstract has been received and provided with contact information if you should have any questions or need to contact anyone related to the abstract submission.
© 2001-2023 Society on NeuroImmune Pharmacology